Contract for the supply of human papillomavirus vaccine
The provision of a vaccine to prevent highgrade cervical intraepithelial neoplasia (CIN grades 2 and 3) and cervical cancer causally related to Human Papillomavirus types 16 and 18, to be used in the national immunisation programme, and deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months
Make the case to bid
Reveal who to approach at COMMERCIAL MEDICINES UNIT, and generate a go-to-market strategy from their news, accounts and people.
- OCID
- a95d8f05-cbba-4e5e-a433-660045692c86
- Stage
- contract · Contract
- Source
- Contracts Finder
- Buyer ref
- CM/PHV/12/5351
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
Assembling the market network…
COMMERCIAL MEDICINES UNIT’s tender network
Assembling the network…
Similar open tenders
Staff Flu Vaccination Programme
Hull City Council
Measles, Mumps and Rubella (MMR) vaccine (2027)
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency